Asthma News: Breaking Asthma News, Comments and Articles. - Page: 5

00:33 EDT 19th April 2015 | BioPortfolio

Asthma News - Page: 5Twitter RSS

Read the latest Asthma News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Asthma.

Search or Follow Our Asthma - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Asthma - Page: 5 News.
You can also follow our Asthma - Page: 5 news stories on Twitter: @asthma_bio

Showing "asthma" News Articles 101 to 125 of 1,000+

Tuesday 24th March 2015

Two Healthcare Informatics Innovator Awardees Use Technology to Manage Population Health and Value-based Reimbursement

ATLANTA, March 24, 2015 /PRNewswire/ -- Two Wellcentive clients, the Children's Health Alliance and Blanchard Valley Health System, have been honored as winners of the annual Healthcare Informatics (HCI) Innovator Awards. Both organizations earned recognition for implementing value-based care strategies and proactively managing the health of their patient populations, using Wellcentive's comprehen...

Stallergenes S.A. (GENP) - Medical Equipment - Deals and Alliances Profile

Recently added to the BioPortfolio report store, Stallergenes S.A. (GENP) - Medical Equipment - Deals and Alliances Profile is a new report from GlobalData published on 2015-02-15. This 19-page report is available in PDF from $250. Summary Stallergenes S.A. (Stallergenes) is a biopharmaceutical company, providing treatment for allergy-related respiratory diseases. The company develops diagnostic...

OPKO Health, Inc. (OPK) - Medical Equipment - Deals and Alliances Profile

Recently added to the BioPortfolio report store, OPKO Health, Inc. (OPK) - Medical Equipment - Deals and Alliances Profile is a new report from GlobalData published on 2015-02-15. This 48-page report is available in PDF from $250. Summary OPKO Health, Inc. (OPKO), formerly eXegenics, Inc., is a biopharmaceutical company. It discovers, develops, and commercializes novel diagnostic technologies an...

Monday 23rd March 2015

Global miRNA Market Outlook to 2018

LONDON, March 23, 2015 /PRNewswire/ -- The recent discovery of miRNA and its wide applicability have sparked off a lot of interest among researchers as well as commercial players. Owing to the same, there are numerous clinical trials being organized all over the world in order to assess the potential of miRNA in diverse fields such as Cancer, Asthma, Heart Disorders, Diabetes, Hepatitis etc. The r...

FDA warns against homeopathic asthma products

Michael JohnsenThe Food and Drug Administration last week warned consumers against using homeoapthic asthma remedies.  read more

4 Things You Should Know When Selecting a Chiropractor in St Petersburg

St. Petersburg, FL, March 23, 2015 --(PR.com)-- Chiropractors on Staff at Revive Medical Spa of St. Petersburg perform life changing adjustments, as well as offering massage therapy in the offices for clients by Licensed Massage Therapists. There are many questions people have when choosing a chiropractor for adjustments and massage therapy. In Florida, St. Petersburg has numerous chiropractors p...

Sensor-embedded inhaler to track asthma of Ky. patients

The personalized asthma management system from Propeller Health will be used as part of a collaboration between public, priva -More- 

Sunday 22nd March 2015

Homeopathic Claims Cloud Asthma Category In Consumer Health Market

FDA officials identify “at least 23” asthma products marketed for asthma and labeled as homeopathic even though the indication is not approved for homeopathics. The consumer health care market for asthma products is made murky also by the status ...

Friday 20th March 2015

FDA Panel Backs GSK Inhaler for Adults, Not Adolescents

Government health advisers say a once-a-day respiratory inhaler from GlaxoSmithKline appears safe and effective for adults with asthma, but not for adolescents. The Food and Drug Administration panel of experts voted 18-2 that evidence submitted by the British drugmaker for its Breo Ellipta inhaler does not support its use in asthma patients ages 12 to 17. That followed a positive vote of 16-4 su...

Caution urged over antibiotic scripts for pregnant women with asthma

Researchers have advised caution when prescribing antibiotics to women with asthma during pregnancy, as it may increase the risk of their child going on to develop the condition as well.

FDA panel backs GSK's asthma drug Breo for adults only

Already approved to treat COPD in the US

GSK and Theravance see FDA nod for asthma indication

An FDA panel has recommended the approval of asthma treatment Breo Ellipta in adults – but voted against supporting its use in children. The FDA’s pulmonary allergy drugs advisory committee and drug safety and risk management wing voted to recommend the approval of the asthma drug, which is co-marketed by GSK and Theravance, as a once-daily inhaled treatment for asthma in patients aged 18 year...

GSK's asthma drug wins FDA panel's backing for use in adults

An FDA advisory panel voted 16-4 Thursday to endorse the approval of GlaxoSmithKline's chronic obstructive pulmonary disease  -More- 

The ethics and money in medicine

In mid-January, a patient called me from her pharmacy, frantic. Her asthma inhalers came to $168 — a sum that she hadn’t been prepared for. But she can’t live without those inhalers, so she withdrew cash from her meager savings account and skipped her blood pressure pills for that month. This is such a familiar […]

Louisville To Use Technology and Innovation to Reduce Burden of Asthma

LOUISVILLE, Ky., March 20, 2015 /PRNewswire/ -- Today marks the start of AIR Louisville, the first-of-its-kind data-driven collaboration among public, private and philanthropic organizations to use digital health technology to improve asthma. Kentucky has the fourth highest adult asthma prevalence in the US and Louisville consistently ranks among the top 20 "most challenging" cities to live in wit...

FDA Panel Backs Breo Ellipta for Asthma in Adults

The panel recommended against approving the long-acting beta-agonist combination therapy for children, primarily due to safety concerns. Medscape Medical News

Thursday 19th March 2015

FDA Panel Recommends Approval Of GSK Asthma Drug For Adults But Not Adolescents

LONDON (dpa-AFX) - An asthma treatment co-developed by GlaxoSmithKline and Theravance has been found safe and effective by a FDA review panel in treating adults but not adolescents.The FDA panel v...

FDA panel backs Breo adult asthma use; rejects adolescents

But GSK is seeking to broaden the use of the drug in asthma in adults and adolescents.

GSK’s Breo Breathing A Little Easier In Asthma, But More Studies Ahead

FDA advisory committee votes to Breo Ellipta for asthma in adults with post-approval safety study, but panel wants additional premarket efficacy and safety data for adolescents.

UPDATE 2-FDA panel backs Glaxo asthma drug for adults, not adolescents

March 19 (Reuters) - GlaxoSmithKline Plc's drug to treat chronic breathing problems is safe and effective enough for adults with asthma to use but not adolescents, an advisory panel to the U.S. Food and Drug Administration concluded on Thursday.

UPDATE 1-FDA panel backs Glaxo asthma drug for adults, not adolescents

March 19 (Reuters) - GlaxoSmithKline Plc's drug to treat chronic breathing problems is safe and effective enough to be approved in adults with asthma, but not adolescents, an advisory panel to the U.S. Food and Drug Administration concluded on Thursd...

FDA advisers says data does not show safety of Glaxo inhaler for adolescents with asthma

Government health advisers say a once-a-day respiratory inhaler from GlaxoSmithKline appears safe and effective for adults with asthma, but not for adolescents.

FDA panel backs Glaxo asthma drug for adults, not adolescents

March 19 (Reuters) - GlaxoSmithKline Plc's drug to treat chronic breathing problems is safe and effective enough to be approved in adults with asthma but not adolescents, an advisory panel to the U.S. Food and Drug Administration concluded on Thursda...

FDA panel backs Breo Ellipta for adults, not children

FDA's Pulmonary-Allergy Drugs Advisory and Drug Safety and Risk Management Advisory committees voted 16-4 to recommend approval of Breo Ellipta fluticasone furoate/vilanterol from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) and

FDA panel backs Glaxo inhaler for adults, not adolescents

Government health advisers say a once-a-day respiratory inhaler from GlaxoSmithKline appears safe and effective for adults with asthma, but not for adolescents.


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks